Clipping of news on Brazilian Culture, Law and Citizenship
14/05/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
Tablet daily use should be taken by persons not infected and at risk of contracting the virus
A committee of health experts supported the United States for the first time, a drug to prevent contamination by the HIV virus.
The Antiviral Drugs Advisory Committee, which advises the U.S. Agency for Food and Drug Administration (FDA, in its English acronym), approved the use of Truvada, a pill everyday to be used by uninfected people would be at greater risk of contracting the AIDS virus.
The use of the drug was approved by 19 votes in favor and three against that Truvada be prescribed for the group considered most at risk, uninfected men who have sex with multiple partners also men.
It was also approved, by majority vote, the prescription of Truvada for people who have partners uninfected with HIV and other groups considered at risk of contracting the virus through sexual activity.
The use of Truvada has been FDA approved for people who already have HIV and is taken with other medicines.
Studies conducted in 2010 showed that Truvada, Gilead Sciences Laboratory California reduced the risk of HIV infection between 44% and 73% in healthy homosexual men and heterosexual partners who are healthy carriers of the HIV virus.
Opposition
The committee vote came after a meeting 11 hours in Silver Spring, Maryland, and a long section of comments.
Some employees of the health sector and community groups active in people with HIV were against approval of the use of Truvada. The groups fear that the drug users develop a false sense of security.
They also fear the emergence of a strain of HIV resistant to the medication.
There is also concern about the high cost of Truvada, which may divert resources from cheaper options.
'We need to slow down. I worry too much about my community not to mention my concerns, "said Joey Terrill, AIDS Healthcare Foundation, a foundation that has campaigned against the drug's approval.
'Truvada must be taken every day, 100% of the time and my experience as a registered nurse tells me that this will not happen, "said the nurse Karen Haughey.
However, others have adopted the committee's decision.
"This puts us closer to a milestone in global efforts to prevent HIV," he said after the vote, Mitchell Warren, executive director of the Coalition for the Defense of AIDS Vaccine.
The FDA is not obliged to follow the advice of the committee, but usually follows. The U.S. agency's final decision must be made on June 15.
Source: R7 News
Our news are taken in full of our partner sites. For this reason, we can not change the content of these up in case of typing errors.
This article was translated by an automatic translation system, and was therefore not reviewed by people.